- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Short dapt with clopidogrel has similar effects that of long term dapt
Overview
Patients with Acute Coronary Syndrome (ACS) are regarded as having a higher long-term risk of cardiovascular events after percutaneous coronary intervention (PCI) compared with patients with the chronic coronary syndrome (CCS). Therefore, the recommended duration of dual antiplatelet therapy (DAPT) after PCI was longer in patients with ACS than in patients with CCS.
A recent study suggests that clopidogrel monotherapy after 1 to 2 months of DAPT is no better than standard 12 months of DAPT among ACS patients with successful PCI. The study findings were published in the JAMA Cardiology today (March 02, 2022).
For more information check out the full story on the link below:
Short DAPT Followed by Clopidogrel monotherapy No Better Than Long term DAPT: JAMA
Speakers
Dr. Nandita Mohan
BDS, MDS( Pedodontics and Preventive Dentistry)